AMERICAN SOCIETY OF CLINICAL ONCOLOGY: Form 990, tax year 2021
View the entire original 990 at ProPublica ↗
- Organization
- AMERICAN SOCIETY OF CLINICAL ONCOLOGY (EIN 13-6180380)
- Tax period
- 2021-01-01 to 2021-12-31
- Filed
- 2022-11-10
- IRS object ID
- 202233149349306463
- Schema version
- 2021v4.2
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule C
- Schedule D
- Schedule F
- Schedule I
- Schedule J
- Schedule O
- Schedule R
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2022-11-10T15:41:45-06:00 | ReturnTs |
| Tax Period End | 2021-12-31 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Firm EIN | 221478099 | PreparerFirmEIN |
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | COHNREZNICK LLP | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 7501 WISCONSIN AVENUE SUITE 400E | AddressLine1Txt |
| City | BETHESDA | CityNm |
| State Abbreviation | MD | StateAbbreviationCd |
| ZIP | 20814 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2021-01-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 136180380 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | AMERICAN SOCIETY OF CLINICAL | BusinessNameLine1Txt |
| Business Name Line2 | ONCOLOGY INC | BusinessNameLine2Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Control | AMER | BusinessNameControlTxt |
| Phone | 5714831300 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 2318 MILL ROAD 800 | AddressLine1Txt |
| City | ALEXANDRIA | CityNm |
| State Abbreviation | VA | StateAbbreviationCd |
| ZIP | 22314 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | LINDA JENSEN | PersonNm |
| Person Title | EVP & CFO | PersonTitleTxt |
| Phone | 5714831300 | PhoneNum |
| Signature | 2022-11-10 | SignatureDt |
| Discuss With Paid Preparer | Yes (1) | DiscussWithPaidPreparerInd |
Signing Officer SigningOfficerGrp
Person Full Name PersonFullName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person First | LINDA | PersonFirstNm |
| Person Last | JENSEN | PersonLastNm |
| Field | Value | IRS element (for citing) |
|---|---|---|
| SSN | 999009999 | SSN |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | LORI ROTHE YOKOBOSKY CPA | PreparerPersonNm |
| PTIN | P01273422 | PTIN |
| Phone | 3016529100 | PhoneNum |
| Preparation | 2022-11-09 | PreparationDt |
Additional Filer Information AdditionalFilerInformation
Trusted Customer TrustedCustomerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Trusted Customer | 3 | TrustedCustomerCd |
| Authentication Assurance Level | AAL1 | AuthenticationAssuranceLevelCd |
| Identity Assurance Level | IAL1 | IdentityAssuranceLevelCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2021 | TaxYr |
| Build TS | 2022-09-23 18:48:47Z | BuildTS |
Form 990 IRS990
Doing Business As Name DoingBusinessAsName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | ASCO | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | CLIFFORD HUDIS MD CEO | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 2318 MILL ROAD 800 | AddressLine1Txt |
| City | ALEXANDRIA | CityNm |
| State Abbreviation | VA | StateAbbreviationCd |
| ZIP | 22314 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $148,501,210 | GrossReceiptsAmt |
| Group Return For Affiliates | 0 | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | WWW.ASCO.ORG | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 1965 | FormationYr |
| Legal Domicile State | NY | LegalDomicileStateCd |
| Activity Or Mission | ASCO IS A PROFESSIONAL ONCOLOGY SOCIETY COMMITTED TO CONQUERING CANCER THROUGHRESEARCH, EDUCATION, AND PROMOTION OF THE HIGHEST QUALITY, EQUITABLE PATIENT CARE. | ActivityOrMissionDesc |
| Voting Members Governing Body | 19 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 19 | VotingMembersIndependentCnt |
| Total Employee | 519 | TotalEmployeeCnt |
| Total Volunteers | 5185 | TotalVolunteersCnt |
| Total Gross UBI | $14,311,943 | TotalGrossUBIAmt |
| Net Unrelated Bus Txbl Incm | $7,677,032 | NetUnrelatedBusTxblIncmAmt |
| PY Contributions Grants | $6,446,971 | PYContributionsGrantsAmt |
| CY Contributions Grants | $7,826,511 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $121,740,555 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $95,200,297 | CYProgramServiceRevenueAmt |
| PY Investment Income | -$4,680,218 | PYInvestmentIncomeAmt |
| CY Investment Income | -$6,626,473 | CYInvestmentIncomeAmt |
| PY Other Revenue | $14,866,774 | PYOtherRevenueAmt |
| CY Other Revenue | $11,188,293 | CYOtherRevenueAmt |
| PY Total Revenue | $138,374,082 | PYTotalRevenueAmt |
| CY Total Revenue | $107,588,628 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $7,819,588 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $4,188,723 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $58,815,087 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $59,715,405 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $0 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $0 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $0 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $68,101,126 | PYOtherExpensesAmt |
| CY Other Expenses | $55,874,509 | CYOtherExpensesAmt |
| PY Total Expenses | $134,735,801 | PYTotalExpensesAmt |
| CY Total Expenses | $119,778,637 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | $3,638,281 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | -$12,190,009 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $279,249,289 | TotalAssetsBOYAmt |
| Total Assets EOY | $283,820,689 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $119,295,053 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $114,592,790 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $159,954,236 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $169,227,899 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part III | Yes (X) | InfoInScheduleOPartIIIInd |
| Mission | SEE SCHEDULE O | MissionDesc |
| Significant New Program Srvc | 0 | SignificantNewProgramSrvcInd |
| Significant Change | 0 | SignificantChangeInd |
| Expense | $34,763,068 | ExpenseAmt |
| Grant | $0 | GrantAmt |
| Revenue | $22,991,694 | RevenueAmt |
| Desc | QUALITY OF CARE: SEE SCHEDULE O | Desc |
Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $26,185,693 | ExpenseAmt |
| Grant | $0 | GrantAmt |
| Revenue | $53,330,502 | RevenueAmt |
| Desc | SCIENTIFIC AND MEDICAL EDUCATION: SEE SCHEDULE O | Desc |
Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $9,491,583 | ExpenseAmt |
| Grant | $161,000 | GrantAmt |
| Revenue | $14,349,944 | RevenueAmt |
| Desc | SCIENTIFIC PUBLICATIONS: SEE SCHEDULE O | Desc |
Prog Srvc Accom Acty Other ProgSrvcAccomActyOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $25,044,237 | ExpenseAmt |
| Grant | $4,027,723 | GrantAmt |
| Revenue | $4,474,437 | RevenueAmt |
| Desc | 1. MEMBERS SERVICES: ASCO WORKS TO SUPPORT AND EDUCATE ITS MORE THAN 45,000 MEMBERS, IN COLLABORATION WITH ITS AFFILIATE, ASCO ASSOCIATION, D/B/A ASSOCIATION FOR CLINICAL ONCOLOGY (ASSOCIATION). ASCO AND THE ASSOCIATION HAVE RECIPROCAL MEMBERSHIP, MEANING THAT EACH MEMBER IS A MEMBER OF BOTH ASCO AND THE ASSOCIATION. ASCO'S MEMBERS VOLUNTEER TO PROVIDE EXPERTISE FOR EDUCATION, PRACTICE GUIDELINES, POLICY, AND OTHER ONCOLOGY LEADERSHIP ACTIVITIES.2. RESEARCH: ASCO IS ACTIVELY ENGAGED IN THE SUPPORT, PROMOTION AND CONDUCT OF CLINICAL CANCER RESEARCH. RESEARCH-RELATED ACTIVITIES INCLUDE:- ORIGINAL RESEARCH: ASCO CONDUCTS RESEARCH TO DEVELOP EVIDENCE THAT INFORMS PATIENT CARE, PUBLIC POLICY, AND EDUCATION. RESEARCH INCLUDES SURVEYS, OBSERVATIONAL STUDIES AND CLINICAL TRIALS. ITS MAJOR CLINICAL TRIAL, TAPUR, IS TESTING THE SAFETY AND EFFICACY OF FDA- APPROVED, TARGETED ANTI-CANCER THERAPIES IN OTHER CANCER TYPES FOR PATIENTS WITH AN INDICATIVE GENOMIC ALTERATION. IN 2020, ASCO LAUNCHED A REGISTRY TO COLLECT AND ANALYZE THE IMPACT OF COVID-19 ON CANCER PATIENT OUTCOMES. - SCIENTIFIC/RESEARCH COLLABORATIONS: ASCO WORKS WITH OTHER STAKEHOLDERS IN THE COMMUNITY, INCLUDING GOVERNMENT AGENCIES, PATIENT ADVOCACY GROUPS, AND OTHER PROFESSIONAL MEDICAL SOCIETIES TO SUPPORT AND PROMOTE RESEARCH THAT INFORMS EVIDENCE- BASED PATIENT CARE. THIS INCLUDES AN ASCO-FDA COLLABORATION TO JOINTLY HOST PUBLIC WORKSHOPS ON EMERGING ISSUES IN RESEARCH AND FDA REVIEW OF NEW THERAPIES.- RESEARCH GRANTS AND AWARDS: ASCO MAKES GRANTS TO ITS 501(C)(3) AFFILIATED ORGANIZATION, CONQUER CANCER FOUNDATION OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (CONQUER CANCER) TO FUND COMPETITIVELY AWARDED RESEARCH GRANTS AND AWARDS. MOST OF THESE GRANTS SUPPORT THE INDEPENDENT RESEARCH INITIATIVES OF CLINICAL INVESTIGATORS.3. CANCER POLICY: ASCO'S POLICY WORK FOCUSES ON THE ISSUES OF ACCESS TO AND DELIVERY OF HIGH-QUALITY AND EQUITABLE CANCER CARE FOR CANCER PATIENTS. WORKING WITH VOLUNTEER ASCO MEMBERS, THE SOCIETY DEVELOPS POSITIONS ADDRESSING ISSUES OF CRITICAL IMPORTANCE TO THE PRACTICE OFONCOLOGY AND PATIENT CARE. ASCO'S POLICY PROGRAMS COVER A BROAD SPECTRUM OF ISSUES, INCLUDING CLINICAL CANCER RESEARCH, HEALTH INSURANCE, CLINICAL PRACTICE, WORKFORCE, DISPARITIES, COST/ACCESS, CANCER SURVIVORSHIP, AND CANCER PREVENTION AND CONTROL. ASCO PROVIDES EDUCATIONAL WORKSHOPS AND MATERIALS, LEGAL ANALYSIS, DEVELOPMENT OF FORMAL COMMENTS AND TESTIMONY, AND SPECIAL STUDIES ON CRITICAL ISSUES FOR THE CANCER COMMUNITY. ASCO ROUTINELY COLLABORATES WITH OTHERS IN THE COMMUNITY TO ADVANCE COMMON GOALS RELATED TO ACCESS TO AND DELIVERY OF HIGH-QUALITY CANCER CARE.4. PATIENT INFORMATION AND OTHER: ASCO PROVIDES IMPORTANT INFORMATION TO THE PUBLIC FREE OF CHARGE THROUGH ITS AWARD-WINNING PATIENT EDUCATION WEBSITE, CANCER.NET (WWW.CANCER.NET), THROUGH A MOBILE APPLICATION, AND OTHER PATIENT EDUCATION MATERIALS. CANCER.NET BRINGS THE EXPERTISE AND RESOURCES OF ASCO TO PEOPLE LIVING WITH CANCER AND THOSE WHO CARE FOR AND CARE ABOUT THEM. CANCER.NET PROVIDES ONCOLOGIST- APPROVED INFORMATION TO HELP PATIENTS AND FAMILIES MAKE INFORMED HEALTH CARE DECISIONS. THE SITE OFFERS COMPREHENSIVE GUIDES TO MORE THAN 120 TYPES OF CANCER AND CANCER-RELATED SYNDROMES, INCLUDING DISEASE-SPECIFIC TREATMENT AND SIDE EFFECTS INFORMATION. EXTENSIVE INFORMATION CAN BE FOUND ON NAVIGATING CANCER CARE, COPING WITH CANCER, CLINICAL TRIALS, MANAGING SIDE EFFECTS, CAREGIVING, SURVIVORSHIP, AND RESEARCH AND ADVOCACY; SELECT CONTENT IS AVAILABLE IN SPANISH, CHINESE, PORTUGUESE, ROMANIAN, ARABIC, GREEK, AND ARMENIAN. CANCER.NET ALSO FEATURES VIDEOS, PODCASTS, AND AN AWARD-WINNING BLOG. | Desc |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Other Prog Srvc Expense | $25,044,237 | TotalOtherProgSrvcExpenseAmt |
| Total Other Prog Srvc Grant | $4,027,723 | TotalOtherProgSrvcGrantAmt |
| Total Other Prog Srvc Revenue | $4,474,437 | TotalOtherProgSrvcRevenueAmt |
| Total Program Service Expenses | $95,484,581 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (1) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (1) | ScheduleBRequiredInd |
| Political Campaign Acty | 0 | PoliticalCampaignActyInd |
| Lobbying Activities | Yes (1) | LobbyingActivitiesInd |
| Subject To Proxy Tax | 0 | SubjectToProxyTaxInd |
| Donor Advised Fund | 0 | DonorAdvisedFundInd |
| Conservation Easements | 0 | ConservationEasementsInd |
| Collections Of Art | 0 | CollectionsOfArtInd |
| Credit Counseling | 0 | CreditCounselingInd |
| Donor Rstr Or Quasi Endowments | 0 | DonorRstrOrQuasiEndowmentsInd |
| Report Land Building Equipment | Yes (1) | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | 0 | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | 0 | ReportProgramRelatedInvstInd |
| Report Other Assets | 0 | ReportOtherAssetsInd |
| Report Other Liabilities | Yes (1) | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | Yes (1) | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | 0 | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | Yes (1) | ConsolidatedAuditFinclStmtInd |
| School Operating | 0 | SchoolOperatingInd |
| Foreign Office | Yes (1) | ForeignOfficeInd |
| Foreign Activities | Yes (1) | ForeignActivitiesInd |
| More Than5000 K To Org | 0 | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | Yes (1) | MoreThan5000KToIndividualsInd |
| Professional Fundraising | 0 | ProfessionalFundraisingInd |
| Fundraising Activities | 0 | FundraisingActivitiesInd |
| Gaming Activities | 0 | GamingActivitiesInd |
| Operate Hospital | 0 | OperateHospitalInd |
| Grants To Organizations | Yes (1) | GrantsToOrganizationsInd |
| Grants To Individuals | 0 | GrantsToIndividualsInd |
| Schedule J Required | Yes (1) | ScheduleJRequiredInd |
| Tax Exempt Bonds | 0 | TaxExemptBondsInd |
| Engaged In Excess Benefit Trans | 0 | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | 0 | PYExcessBenefitTransInd |
| Loan Outstanding | 0 | LoanOutstandingInd |
| Grant To Related Person | 0 | GrantToRelatedPersonInd |
| Business Rln With Org Mem | 0 | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | 0 | BusinessRlnWithFamMemInd |
| Business Rln With35 Ctrl Ent | 0 | BusinessRlnWith35CtrlEntInd |
| Deductible Non Cash Contri | 0 | DeductibleNonCashContriInd |
| Deductible Art Contribution | 0 | DeductibleArtContributionInd |
| Terminate Operations | 0 | TerminateOperationsInd |
| Partial Liquidation | 0 | PartialLiquidationInd |
| Disregarded Entity | Yes (1) | DisregardedEntityInd |
| Related Entity | Yes (1) | RelatedEntityInd |
| Related Organization Ctrl Ent | Yes (1) | RelatedOrganizationCtrlEntInd |
| Transaction With Control Ent | Yes (1) | TransactionWithControlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | Yes (1) | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | 0 | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (1) | ScheduleORequiredInd |
| IRP Document | 361 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Backup Wthld Compliance | Yes (1) | BackupWthldComplianceInd |
| Employee | 519 | EmployeeCnt |
| Employment Tax Returns Filed | Yes (1) | EmploymentTaxReturnsFiledInd |
| Unrelated Bus Incm Over Limit | Yes (1) | UnrelatedBusIncmOverLimitInd |
| Form990 T Filed | Yes (1) | Form990TFiledInd |
| Foreign Financial Account | 0 | ForeignFinancialAccountInd |
| Prohibited Tax Shelter Trans | 0 | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | 0 | TaxablePartyNotificationInd |
| Nondeductible Contributions | 0 | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | 0 | QuidProQuoContributionsInd |
| Form8282 Property Disposed Of | 0 | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | 0 | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | 0 | PayPremiumsPrsnlBnftCntrctInd |
| Indoor Tanning Services | 0 | IndoorTanningServicesInd |
| Subj To Tax Rmnrtn Ex Prcht Pymt | 0 | SubjToTaxRmnrtnExPrchtPymtInd |
| Subject To Excs Tax Net Invst Inc | 0 | SubjectToExcsTaxNetInvstIncInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 19 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 19 | IndependentVotingMemberCnt |
| Family Or Business Rln | Yes (1) | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | 0 | DelegationOfMgmtDutiesInd |
| Change To Org Documents | Yes (1) | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | 0 | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | Yes (1) | MembersOrStockholdersInd |
| Election Of Board Members | Yes (1) | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | Yes (1) | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (1) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (1) | MinutesOfCommitteesInd |
| Officer Mailing Address | 0 | OfficerMailingAddressInd |
| Local Chapters | 0 | LocalChaptersInd |
| Form990 Provided To Gvrn Body | Yes (1) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (1) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (1) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (1) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (1) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (1) | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (1) | CompensationProcessCEOInd |
| Compensation Process Other | Yes (1) | CompensationProcessOtherInd |
| Investment In Joint Venture | 0 | InvestmentInJointVentureInd |
| States Where Copy Of Return Is Fld | CA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NY | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | VA | StatesWhereCopyOfReturnIsFldCd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | LINDA JENSEN EVP & CFO | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Phone | 5714831300 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 2318 MILL ROAD SUITE 800 | AddressLine1Txt |
| City | ALEXANDRIA | CityNm |
| State Abbreviation | VA | StateAbbreviationCd |
| ZIP | 22314 | ZIPCd |
Form990 Part VII Section A Form990PartVIISectionAGrp (40 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | OfficerOfficerInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | Key EmployeeKeyEmployeeInd | Highest Compensated EmployeeHighestCompensatedEmployeeInd |
|---|---|---|---|---|---|---|---|---|---|
| HOWARD A BURRIS III MD | |||||||||
| CHAIR/PAST PRESIDENT | 1.00 | 3.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | ||
| LORI J PIERCE MD | |||||||||
| CHAIR/PRESIDENT | 1.00 | 1.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | ||
| MONICA M BERTAGNOLLI MD | |||||||||
| PAST PRESIDENT (PARTIAL YR) | 1.00 | 1.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | ||
| EVERETT E VOKES MD | |||||||||
| PRESIDENT | 1.00 | 1.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | ||
| ERIC P WINER MD | |||||||||
| PRESIDENT- ELECT | 1.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | |||
| ELIZABETH A MITTENDORF MD | |||||||||
| TREASURER- ELECT | 1.00 | 1.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | ||
| LAURIE E GASPAR MD MBA | |||||||||
| TREASURER | 1.00 | 1.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | ||
| ETHAN M BASCH MD | |||||||||
| BOARD MEMBER | 1.00 | Yes (X) | $0 | $0 | $0 | ||||
| A WILLIAM BLACKSTOCK MD | |||||||||
| BOARD MEMBER | 1.00 | 1.00 | Yes (X) | $0 | $0 | $0 | |||
| LISA A CAREY MD | |||||||||
| BOARD MEMBER | 1.00 | Yes (X) | $0 | $0 | $0 | ||||
| ENRIQUE SOTO PEREZ DE CELIS MD PHD | |||||||||
| BOARD MEMBER | 1.00 | Yes (X) | $0 | $0 | $0 | ||||
| LEE M ELLIS MD | |||||||||
| BOARD MEMBER | 1.00 | 1.00 | Yes (X) | $0 | $0 | $0 | |||
| TARA O HENDERSON MD MPH | |||||||||
| BOARD MEMBER | 1.00 | Yes (X) | $0 | $0 | $0 | ||||
| RESHMA JAGSI MD | |||||||||
| BOARD MEMBER (PARTIAL YR) | 1.00 | 1.00 | Yes (X) | $0 | $0 | $0 | |||
| MICHAEL P KOSTY MD | |||||||||
| BOARD MEMBER (PARTIAL YR) | 1.00 | 1.00 | Yes (X) | $0 | $0 | $0 | |||
| TONY S K MOK BMSC MD | |||||||||
| BOARD MEMBER | 1.00 | 1.00 | Yes (X) | $0 | $0 | $0 | |||
| ELIZABETH R PLIMACK MD MS | |||||||||
| BOARD MEMBER | 1.00 | Yes (X) | $0 | $0 | $0 | ||||
| ERIC J SMALL MD | |||||||||
| BOARD MEMBER (PARTIAL YR) | 1.00 | 1.00 | Yes (X) | $0 | $0 | $0 | |||
| MICHAEL A THOMPSON MD PHD | |||||||||
| BOARD MEMBER | 1.00 | Yes (X) | $0 | $0 | $0 | ||||
| TRACEY F WEISBERG MD | |||||||||
| BOARD MEMBER | 1.00 | Yes (X) | $0 | $0 | $0 | ||||
| MARIANA CHAVEZ MACGREGOR MD | |||||||||
| BOARD MEMBER | 1.00 | Yes (X) | $0 | $0 | $0 | ||||
| TAOFEEK OWONIKOKO MD PHD | |||||||||
| BOARD MEMBER | 1.00 | Yes (X) | $0 | $0 | $0 | ||||
| GLADYS RODRIGUEZ MD | |||||||||
| BOARD MEMBER | 1.00 | Yes (X) | $0 | $0 | $0 | ||||
| CLIFFORD HUDIS MD | |||||||||
| CHIEF EXECUTIVE OFFICER | 30.00 | 7.50 | Yes (X) | $888,725 | $0 | $21,750 | |||
| DINA MICHELS ESQ | |||||||||
| SECRETARY, EVP & COO | 33.50 | 4.00 | Yes (X) | $595,328 | $0 | $40,279 | |||
| LINDA JENSEN CPA | |||||||||
| EVP AND CFO | 30.00 | 7.50 | Yes (X) | $408,048 | $0 | $42,559 | |||
| SEAN KHOZIN MD | |||||||||
| EVP & CEO OF CANCERLINQ | 37.50 | $409,799 | $0 | $28,835 | Yes (X) | ||||
| JULIE R GRALOW MD | |||||||||
| EVP & CHIEF MEDICAL OFFICER | 37.50 | $483,927 | $0 | $37,233 | Yes (X) | ||||
| CHRISTOPHER MERLAN | |||||||||
| EVP & CHIEF DIGITAL OFFICE | 37.50 | $421,998 | $0 | $47,344 | Yes (X) | ||||
| JAMIE VON ROENN MD | |||||||||
| VP, EDU., SCIENCE & PROF. | 37.50 | $410,114 | $0 | $30,545 | Yes (X) | ||||
| NANCY DALY MS MPH | |||||||||
| EVP & CEO CONQUER CANCER F | 1.00 | 36.50 | $415,557 | $0 | $46,187 | Yes (X) | |||
| ANGELA COCHRAN | |||||||||
| VP, PUBLISHING | 37.50 | $248,480 | $0 | $35,036 | Yes (X) | ||||
| KRISTIN LUDWIG | |||||||||
| VP, MARKETING & COMMUNICAT | 37.50 | $311,775 | $0 | $21,750 | Yes (X) | ||||
| AMANDA DAVIS-AITKEN | |||||||||
| VICE PRESIDENT, MEETING SV | 37.50 | $261,391 | $0 | $27,979 | Yes (X) | ||||
| BARTON LAWYER | |||||||||
| VICE PRESIDENT - IT | 37.50 | $249,998 | $0 | $46,718 | Yes (X) | ||||
| STEPHEN GRUBBS MD | |||||||||
| VICE PRESIDENT, CARE DELIV | 37.50 | $400,196 | $0 | $39,421 | Yes (X) | ||||
| ROBERT MILLER MD | |||||||||
| MEDICAL DIRECTOR, CANCERLI | 37.50 | $361,599 | $0 | $46,863 | Yes (X) | ||||
| CARMEN JACKSON | |||||||||
| CHIEF OF OPERATIONS, CLQ | 37.50 | $305,276 | $0 | $47,158 | Yes (X) | ||||
| ANIL NAIR | |||||||||
| CHIEF TECHNOLOGY OFFICER, | 37.50 | $299,475 | $0 | $37,248 | Yes (X) | ||||
| DEBORAH KAMIN RN PHD | |||||||||
| VP POLICY & ADVOCAY | 37.50 | $308,317 | $0 | $43,437 | Yes (X) | ||||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $6,780,003 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $0 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $640,342 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 216 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | 0 | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (1) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | 0 | CompensationFromOtherSrcsInd |
Contractor Compensation ContractorCompensationGrp (5 entries)
| Address Line1ContractorAddress/USAddress/AddressLine1Txt | CityContractorAddress/USAddress/CityNm | State AbbreviationContractorAddress/USAddress/StateAbbreviationCd | ZIPContractorAddress/USAddress/ZIPCd | ServicesServicesDesc | CompensationCompensationAmt |
|---|---|---|---|---|---|
| SPARGO INC | |||||
| 11208 WAPLES MILL ROAD 112 | FAIRFAX | VA | 22030 | EVENT MANAGEMENT | $5,080,732 |
| TEMPUS LABS LLC | |||||
| 600 WEST CHICAGO AVE | CHICAGO | IL | 60654 | DATA CURATION | $4,547,807 |
| CONCERTO HEALTH AI SOLUTIONS LLC | |||||
| 501 BOYLSTON ST | BOSTON | MA | 02116 | DATA TECHNOLOGY | $3,714,413 |
| PUBLICIS SAPIENT | |||||
| 1515 NORTH COURTHOUSE ROAD 4TH FLO | ARLINGTON | VA | 22201 | DIG. TRANSFORMATION | $1,967,426 |
| M BOOTH HEALTH LLC | |||||
| 111 5TH AVE | NEW YORK | NY | 10003 | COMMUNICATIONS & CONSULTING | $1,071,805 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct Rcvd Greater Than100 K | 78 | CntrctRcvdGreaterThan100KCnt |
| Related Organizations | $7,826,511 | RelatedOrganizationsAmt |
| Total Contributions | $7,826,511 | TotalContributionsAmt |
Program Service Revenue ProgramServiceRevenueGrp (5 entries)
| DescDesc | BusinessBusinessCd | Total Revenue ColumnTotalRevenueColumnAmt | Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt | Unrelated Business RevenueUnrelatedBusinessRevenueAmt |
|---|---|---|---|---|
| EDUCATIONAL MTGS & FEE | 900099 | $53,330,502 | $46,286,080 | $7,044,422 |
| QUALITY OF CARE | 900099 | $22,991,694 | $22,991,694 | |
| SCIENTIFIC PUBLICATION | 511190 | $14,349,944 | $7,082,423 | $7,267,521 |
| RESEARCH | 900099 | $4,322,682 | $4,322,682 | |
| OTHER | 900099 | $151,755 | $151,755 |
Total Oth Program Service Rev TotalOthProgramServiceRevGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $53,720 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $53,720 | RelatedOrExemptFuncIncomeAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Revenue | $95,200,297 | TotalProgramServiceRevenueAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $4,026,599 | TotalRevenueColumnAmt |
| Exclusion | $4,026,599 | ExclusionAmt |
Royalties Revenue RoyaltiesRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $11,188,293 | TotalRevenueColumnAmt |
| Exclusion | $11,188,293 | ExclusionAmt |
Gross Amount Sales Assets GrossAmountSalesAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $30,259,510 | SecuritiesAmt |
Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $40,912,582 | SecuritiesAmt |
Gain Or Loss GainOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | -$10,653,072 | SecuritiesAmt |
Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | -$10,653,072 | TotalRevenueColumnAmt |
| Exclusion | -$10,653,072 | ExclusionAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $107,588,628 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $80,888,354 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $14,311,943 | UnrelatedBusinessRevenueAmt |
| Exclusion | $4,561,820 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part IX | Yes (X) | InfoInScheduleOPartIXInd |
Grants To Domestic Orgs GrantsToDomesticOrgsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $4,165,660 | TotalAmt |
| Program Services | $4,165,660 | ProgramServicesAmt |
Foreign Grants ForeignGrantsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $23,063 | TotalAmt |
| Program Services | $23,063 | ProgramServicesAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $5,559,490 | TotalAmt |
| Program Services | $4,000,579 | ProgramServicesAmt |
| Management And General | $1,558,911 | ManagementAndGeneralAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $42,467,496 | TotalAmt |
| Program Services | $30,683,434 | ProgramServicesAmt |
| Management And General | $11,784,062 | ManagementAndGeneralAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $3,173,377 | TotalAmt |
| Program Services | $2,169,504 | ProgramServicesAmt |
| Management And General | $1,003,873 | ManagementAndGeneralAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $4,920,266 | TotalAmt |
| Program Services | $3,363,777 | ProgramServicesAmt |
| Management And General | $1,556,489 | ManagementAndGeneralAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $3,594,776 | TotalAmt |
| Program Services | $2,457,596 | ProgramServicesAmt |
| Management And General | $1,137,180 | ManagementAndGeneralAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $819,829 | TotalAmt |
| Program Services | $327,201 | ProgramServicesAmt |
| Management And General | $492,628 | ManagementAndGeneralAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $194,067 | TotalAmt |
| Management And General | $194,067 | ManagementAndGeneralAmt |
Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $66,140 | TotalAmt |
| Management And General | $66,140 | ManagementAndGeneralAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $18,649,631 | TotalAmt |
| Program Services | $16,410,543 | ProgramServicesAmt |
| Management And General | $2,239,088 | ManagementAndGeneralAmt |
Advertising AdvertisingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $5,027,126 | TotalAmt |
| Program Services | $5,003,918 | ProgramServicesAmt |
| Management And General | $23,208 | ManagementAndGeneralAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,096,676 | TotalAmt |
| Program Services | $1,513,917 | ProgramServicesAmt |
| Management And General | $582,759 | ManagementAndGeneralAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $9,834,857 | TotalAmt |
| Program Services | $9,430,467 | ProgramServicesAmt |
| Management And General | $404,390 | ManagementAndGeneralAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,398,004 | TotalAmt |
| Program Services | $1,331,336 | ProgramServicesAmt |
| Management And General | $66,668 | ManagementAndGeneralAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $349,952 | TotalAmt |
| Program Services | $282,469 | ProgramServicesAmt |
| Management And General | $67,483 | ManagementAndGeneralAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,168,888 | TotalAmt |
| Program Services | $2,059,898 | ProgramServicesAmt |
| Management And General | $108,990 | ManagementAndGeneralAmt |
Interest InterestGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,289,357 | TotalAmt |
| Program Services | $768,199 | ProgramServicesAmt |
| Management And General | $521,158 | ManagementAndGeneralAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $3,857,950 | TotalAmt |
| Program Services | $2,298,567 | ProgramServicesAmt |
| Management And General | $1,559,383 | ManagementAndGeneralAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $647,450 | TotalAmt |
| Program Services | $234,023 | ProgramServicesAmt |
| Management And General | $413,427 | ManagementAndGeneralAmt |
Other Expenses OtherExpensesGrp (4 entries)
| DescDesc | TotalTotalAmt | Program ServicesProgramServicesAmt | Management And GeneralManagementAndGeneralAmt |
|---|---|---|---|
| UBI TAX- FEDERAL AND ST | $3,362,389 | $3,362,389 | |
| CLINICAL SITE PAYMENTS | $2,990,900 | $2,990,900 | |
| PUBLICATIONS & PRODUCTI | $2,373,249 | $2,368,874 | $4,375 |
| DUES & SUBSCRIPTIONS | $563,864 | $229,763 | $334,101 |
All Other Expenses AllOtherExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $184,180 | TotalAmt |
| Program Services | $8,504 | ProgramServicesAmt |
| Management And General | $175,676 | ManagementAndGeneralAmt |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $119,778,637 | TotalAmt |
| Program Services | $95,484,581 | ProgramServicesAmt |
| Management And General | $24,294,056 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| EOY | $103 | EOYAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $19,356,599 | BOYAmt |
| EOY | $25,343,458 | EOYAmt |
Accounts Receivable AccountsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $26,710,378 | BOYAmt |
| EOY | $13,783,464 | EOYAmt |
Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $5,600,000 | BOYAmt |
| EOY | $4,696,784 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $5,424,995 | BOYAmt |
| EOY | $5,397,152 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Bldg Equip Cost Or Other Bss | $82,065,544 | LandBldgEquipCostOrOtherBssAmt |
| Land Bldg Equip Accum Deprec | $35,134,679 | LandBldgEquipAccumDeprecAmt |
Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $48,956,971 | BOYAmt |
| EOY | $46,930,865 | EOYAmt |
Investments Pub Traded Sec InvestmentsPubTradedSecGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $173,200,346 | BOYAmt |
| EOY | $181,953,164 | EOYAmt |
Other Assets Total OtherAssetsTotalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $5,715,699 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $279,249,289 | BOYAmt |
| EOY | $283,820,689 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $10,180,370 | BOYAmt |
| EOY | $11,649,507 | EOYAmt |
Deferred Revenue DeferredRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $38,354,168 | BOYAmt |
| EOY | $46,913,692 | EOYAmt |
Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $38,400,000 | BOYAmt |
| EOY | $0 | EOYAmt |
Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $15,345,000 | BOYAmt |
| EOY | $49,295,410 | EOYAmt |
Other Liabilities OtherLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $17,015,515 | BOYAmt |
| EOY | $6,734,181 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $119,295,053 | BOYAmt |
| EOY | $114,592,790 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows FASB117 | Yes (X) | OrganizationFollowsFASB117Ind |
No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $159,229,656 | BOYAmt |
| EOY | $168,691,045 | EOYAmt |
Donor Restriction Net Assets DonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $724,580 | BOYAmt |
| EOY | $536,854 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $159,954,236 | BOYAmt |
| EOY | $169,227,899 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $279,249,289 | BOYAmt |
| EOY | $283,820,689 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part XI | Yes (X) | InfoInScheduleOPartXIInd |
| Reconcilation Revenue Expnss | -$12,190,009 | ReconcilationRevenueExpnssAmt |
| Net Unrlzd Gains Losses Invst | $20,071,318 | NetUnrlzdGainsLossesInvstAmt |
| Investment Expense | $66,140 | InvestmentExpenseAmt |
| Other Changes In Net Assets | $1,326,214 | OtherChangesInNetAssetsAmt |
| Info In Schedule O Part XII | Yes (X) | InfoInScheduleOPartXIIInd |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | 0 | AccountantCompileOrReviewInd |
| FS Audited | Yes (1) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Consolidated Basis Fincl Stmt | Yes (X) | ConsolidatedBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (1) | AuditCommitteeInd |
| Federal Grant Audit Required | 0 | FederalGrantAuditRequiredInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Publicly Supported Org509a2 | Yes (X) | PubliclySupportedOrg509a2Ind |
Gifts Grants Contris Rcvd509 GiftsGrantsContrisRcvd509Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $9,978,694 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $8,575,801 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $7,525,300 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $6,446,971 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $7,826,511 | CurrentTaxYearAmt |
| Total | $40,353,277 | TotalAmt |
Gross Receipts Admissions GrossReceiptsAdmissionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $93,297,144 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $136,574,903 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $123,116,955 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $98,737,324 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $80,888,354 | CurrentTaxYearAmt |
| Total | $532,614,680 | TotalAmt |
Total509 Total509Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $103,275,838 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $145,150,704 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $130,642,255 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $105,184,295 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $88,714,865 | CurrentTaxYearAmt |
| Total | $572,967,957 | TotalAmt |
Amounts Rcvd Dsqlfy Person AmountsRcvdDsqlfyPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year | $75,000 | CurrentTaxYearAmt |
| Total | $75,000 | TotalAmt |
Substantial Contributors Amt SubstantialContributorsAmtGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Subst And Dsqlfy Prsns Tot SubstAndDsqlfyPrsnsTotGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year | $75,000 | CurrentTaxYearAmt |
| Total | $75,000 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Support Total509 | $572,892,957 | PublicSupportTotal509Amt |
Gross Investment Income509 GrossInvestmentIncome509Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $5,969,247 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $7,763,043 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $8,610,595 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $18,248,056 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $15,214,892 | CurrentTaxYearAmt |
| Total | $55,805,833 | TotalAmt |
Investment Income And UBTI InvestmentIncomeAndUBTIGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $5,969,247 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $7,763,043 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $8,610,595 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $18,248,056 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $15,214,892 | CurrentTaxYearAmt |
| Total | $55,805,833 | TotalAmt |
Net Income From Other UBI NetIncomeFromOtherUBIGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $2,871,782 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $4,855,029 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $7,776,132 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $8,302,393 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $7,677,032 | CurrentTaxYearAmt |
| Total | $31,482,368 | TotalAmt |
Other Income509 OtherIncome509Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $248,859 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $255,345 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $251,085 | CurrentTaxYearMinus2YearsAmt |
| Total | $755,289 | TotalAmt |
Total Support Calendar Year TotalSupportCalendarYearGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $112,365,726 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $158,024,121 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $147,280,067 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $131,734,744 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $111,606,789 | CurrentTaxYearAmt |
| Total | $661,011,447 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Support CY509 | 0.86670 | PublicSupportCY509Pct |
| Public Support PY509 | 0.88530 | PublicSupportPY509Pct |
| Investment Income CY | 0.08440 | InvestmentIncomeCYPct |
| Investment Income PY | 0.07120 | InvestmentIncomePYPct |
| Thirty Thr Pct Suprt Tests CY509 | Yes (X) | ThirtyThrPctSuprtTestsCY509Ind |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule C IRS990ScheduleC
Total Grassroots Lobbying TotalGrassrootsLobbyingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $0 | FilingOrganizationsTotalAmt |
Total Direct Lobbying TotalDirectLobbyingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $0 | FilingOrganizationsTotalAmt |
Total Lobbying Expend TotalLobbyingExpendGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $0 | FilingOrganizationsTotalAmt |
Other Exempt Purpose Expend OtherExemptPurposeExpendGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $95,484,581 | FilingOrganizationsTotalAmt |
Total Exempt Purpose Expend TotalExemptPurposeExpendGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $95,484,581 | FilingOrganizationsTotalAmt |
Lobbying Nontaxable Amount LobbyingNontaxableAmountGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $1,000,000 | FilingOrganizationsTotalAmt |
Grassroots Nontaxable GrassrootsNontaxableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $250,000 | FilingOrganizationsTotalAmt |
Tot Lbbyng Grassroot Mns Non Tx TotLbbyngGrassrootMnsNonTxGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $0 | FilingOrganizationsTotalAmt |
Tot Lbby Expend Mns Lbbyng Non Tx TotLbbyExpendMnsLbbyngNonTxGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $0 | FilingOrganizationsTotalAmt |
Avg Lobbying Nontaxable Amount AvgLobbyingNontaxableAmountGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Year Minus3 | $1,000,000 | CurrentYearMinus3Amt |
| Current Year Minus2 | $1,000,000 | CurrentYearMinus2Amt |
| Current Year Minus1 | $1,000,000 | CurrentYearMinus1Amt |
| Current Year | $1,000,000 | CurrentYearAmt |
| Total | $4,000,000 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Lobbying Ceiling | $6,000,000 | LobbyingCeilingAmt |
Avg Total Lobbying Expend AvgTotalLobbyingExpendGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Year Minus3 | $198,306 | CurrentYearMinus3Amt |
| Current Year Minus2 | $43,604 | CurrentYearMinus2Amt |
| Current Year Minus1 | $0 | CurrentYearMinus1Amt |
| Current Year | $0 | CurrentYearAmt |
| Total | $241,910 | TotalAmt |
Avg Grassroots Nontaxable AvgGrassrootsNontaxableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Year Minus3 | $250,000 | CurrentYearMinus3Amt |
| Current Year Minus2 | $250,000 | CurrentYearMinus2Amt |
| Current Year Minus1 | $250,000 | CurrentYearMinus1Amt |
| Current Year | $250,000 | CurrentYearAmt |
| Total | $1,000,000 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grassroots Ceiling | $1,500,000 | GrassrootsCeilingAmt |
Avg Grassroots Lobbying Expend AvgGrassrootsLobbyingExpendGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Year Minus3 | $1,947 | CurrentYearMinus3Amt |
| Current Year Minus2 | $263 | CurrentYearMinus2Amt |
| Current Year Minus1 | $0 | CurrentYearMinus1Amt |
| Current Year | $0 | CurrentYearAmt |
| Total | $2,210 | TotalAmt |
Schedule D IRS990ScheduleD
Land LandGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $7,342,677 | OtherCostOrOtherBasisAmt |
| Book Value | $7,342,677 | BookValueAmt |
Buildings BuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $46,941,779 | OtherCostOrOtherBasisAmt |
| Depreciation | $15,774,810 | DepreciationAmt |
| Book Value | $31,166,969 | BookValueAmt |
Leasehold Improvements LeaseholdImprovementsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $780,214 | OtherCostOrOtherBasisAmt |
| Depreciation | $774,926 | DepreciationAmt |
| Book Value | $5,288 | BookValueAmt |
Equipment EquipmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $5,159,032 | OtherCostOrOtherBasisAmt |
| Depreciation | $3,814,409 | DepreciationAmt |
| Book Value | $1,344,623 | BookValueAmt |
Other Land Buildings OtherLandBuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $21,841,842 | OtherCostOrOtherBasisAmt |
| Depreciation | $14,770,534 | DepreciationAmt |
| Book Value | $7,071,308 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Land Buildings | $46,930,865 | TotalBookValueLandBuildingsAmt |
Other Liabilities Org OtherLiabilitiesOrgGrp (3 entries)
| DescDesc | AmtAmt |
|---|---|
| DEFERRED COMPENSATION LIABILITY | $3,244,563 |
| OPERATING LEASE OBLIGATION | $3,167,141 |
| ACCRUED TAXES PAYABLE | $322,477 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Liability | $6,734,181 | TotalLiabilityAmt |
| Footnote Text | Yes (X) | FootnoteTextInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART X, LINE 2: | FormAndLineReferenceDesc |
| Explanation | IN PART: THE SOCIETY IS A NON-PROFIT ORGANIZATION EXEMPT FROM FEDERAL INCOME TAXES UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE (THE "IRC"). IT HAS BEEN GRANTED PUBLIC CHARITY STATUS BY THE INTERNAL REVENUE SERVICE (THE "IRS") AND HAS BEEN CLASSIFIED AS OTHER THAN A PRIVATE FOUNDATION. CANCERLINQ, AND ASCO LEASING LLC ARE DISREGARDED ENTITIES FOR INCOME TAX PURPOSES AND INCLUDED WITH THE SOCIETY'S RETURN. THE SOCIETY RECEIVES TAXABLE REVENUE RELATED TO ADVERTISING. FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020, ASCO RECORDED APPROXIMATELY $3,350,336 AND $3,495,000, RESPECTIVELY, IN NET FEDERAL AND STATE INCOME TAXES. AS OF DECEMBER 31, 2021 AND 2020, THE ORGANIZATION HAS OUTSTANDING DEFERRED TAX ASSETS RELATED TO THE EXCESS OF A TAX "DEDUCTION LIMITATION ON CHARITABLE CONTRIBUTIONS OF APPROXIMATELY $4,428,000 AND $4,044,000, RESPECTIVELY, WHICH MAY BE CARRIED FORWARD FOR A MAXIMUM OF FIVE YEARS THROUGH 2024. MANAGEMENT ASSESSED THE REALIZATION OF ITS DEFERRED TAX ASSETS AND RECORDED A FULL VALUATION ALLOWANCE AS MANAGEMENT BELIEVES THAT IT IS MORE LIKELY THAN NOT THAT SOME OR ALL OF ITS DEFERRED TAX ASSETS WILL NOT BE REALIZED BEFORE THEIR EXPIRATION. THE ORGANIZATION ACCOUNTS FOR UNCERTAINTY IN INCOME TAXES IN ACCORDANCE WITH THE INCOME TAX TOPIC OF THE FINANCIAL ACCOUNTING STANDARDS BOARD ACCOUNTING STANDARDS CODIFICATION ("FASB ASC"). THE ORGANIZATION BELIEVES THAT IT HAS APPROPRIATE SUPPORT FOR ANY TAX POSITIONS TAKEN AND, AS SUCH, DOES NOT HAVE ANY UNCERTAIN TAX POSITIONS THAT ARE MATERIAL TO THE CONSOLIDATED FINANCIAL STATEMENTS. GENERALLY, THE ORGANIZATION IS NO LONGER SUBJECT TO INCOME TAX EXAMINATIONS BY THE U.S. FEDERAL, STATE OR LOCAL TAX AUTHORITIES FOR YEARS BEFORE 2018. | ExplanationTxt |
Schedule F IRS990ScheduleF
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (1) | GrantRecordsMaintainedInd |
Account Activities Outside US AccountActivitiesOutsideUSGrp (6 entries)
| RegionRegionTxt | OfficesOfficesCnt | EmployeeEmployeeCnt | Type Of Activities ConductedTypeOfActivitiesConductedTxt | Specific Services ProvidedSpecificServicesProvidedTxt | Region Total ExpendituresRegionTotalExpendituresAmt |
|---|---|---|---|---|---|
| EAST ASIA AND THE PACIFIC | 0 | 0 | PROGRAM SERVICES | OUTREACH & EDUCATION | $9,833 |
| EUROPE (INCLUDING ICELAND & GREENLAND) | 0 | 0 | PROGRAM SERVICES, GRANTMAKING | OUTREACH & EDUCATION | $70,913 |
| NORTH AMERICA | 0 | 0 | PROGRAM SERVICES | OUTREACH & EDUCATION | $9,000 |
| SOUTH AMERICA | 0 | 0 | PROGRAM SERVICES | OUTREACH & EDUCATION | $5,500 |
| SOUTH ASIA | 0 | 0 | PROGRAM SERVICES | OUTREACH & EDUCATION | $5,000 |
| SUB-SAHARAN AFRICA | 0 | 0 | PROGRAM SERVICES | OUTREACH & EDUCATION | $3,000 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Subtotal Offices | 0 | SubtotalOfficesCnt |
| Subtotal Employees | 0 | SubtotalEmployeesCnt |
| Continuation Total Office | 0 | ContinuationTotalOfficeCnt |
| Continuation Total Employee | 0 | ContinuationTotalEmployeeCnt |
| Total Office | 0 | TotalOfficeCnt |
| Total Employee | 0 | TotalEmployeeCnt |
| Subtotal Spent | $103,246 | SubtotalSpentAmt |
| Continuation Spent | $0 | ContinuationSpentAmt |
| Total Spent | $103,246 | TotalSpentAmt |
Foreign Individuals Grants ForeignIndividualsGrantsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Type Of Assistance | CANCER COMMUNITY SUPPORT | TypeOfAssistanceTxt |
| Region | EUROPE (INCLUDING ICELAND & GREENLAND) | RegionTxt |
| Recipient | 1 | RecipientCnt |
| Cash Grant | $23,063 | CashGrantAmt |
| Manner Of Cash Disbursement | WIRE | MannerOfCashDisbursementTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Transfer To Foreign Corp | 0 | TransferToForeignCorpInd |
| Interest In Foreign Trust | 0 | InterestInForeignTrustInd |
| Foreign Corp Ownership | 0 | ForeignCorpOwnershipInd |
| Passive Foreign Investmest Co | 0 | PassiveForeignInvestmestCoInd |
| Foreign Partnership | 0 | ForeignPartnershipInd |
| Boycott Countries | Yes (1) | BoycottCountriesInd |
Supplemental Information Detail SupplementalInformationDetail (3 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART I, LINE 2: | ASCO PROVIDED HONORARIA, VIRTUAL BOOTH FEES AND EXPENSE REIMBURSEMENTS TO MEETING SPEAKERS AND PRESENTERS. HONORARIA AND EXPENSE REIMBURSEMENTS WERE PAID DIRECTLY TO THE PRESENTERS. VIRTUAL BOOTH FEES WERE PAID TO THE VENDOR. |
| PART I, LINE 3: | THE ACCRUAL METHOD WAS USED TO ACCOUNT FOR EXPENDITURES IN RELATION TO BOTH FOREIGN PROGRAM SERVICES & GRANTMAKING ACTIVITIES. |
| PART III ACCOUNTING METHOD: |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (1) | GrantRecordsMaintainedInd |
Recipient Table RecipientTable (12 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Recipient EINRecipientEIN | IRC SectionIRCSectionDesc | Cash GrantCashGrantAmt | Non Cash AssistanceNonCashAssistanceAmt | Purpose Of GrantPurposeOfGrantTxt |
|---|---|---|---|---|---|---|---|---|
| ASCO ASSOCIATION | ||||||||
| 2318 MILL RD SUITE 800 | ALEXANDRIA | VA | 22314 | 833561693 | 501(C)(6) | $40,000 | $0 | MISSION ENDOWMENT FOR MEMBERS SERVICES FOR INTERNATIONAL MEMBERSHIP |
| BANNER MEDICAL GROUP | ||||||||
| 1 N CENTRAL AVE SUITE 160 | PHOENIX | AZ | 85004 | 900532830 | 501(C)(3) | $60,000 | $0 | CONTRIBUTION |
| BOARD OF REGENTS OF THE UNIVERSITY OF THE UNIVERSITY OF MICHIGAN | ||||||||
| 3003 S STATE ST SUITE 8000 | ANN ARBOR | MI | 48109 | 386006309 | 501(C)(3) | $119,167 | $0 | CONTRIBUTION |
| BRIGHAM & WOMEN'S HOSPITAL INC | ||||||||
| 75 FRANCIS ST | BOSTON | MA | 02116 | 042312909 | 501(C)(3) | $30,000 | $0 | CONTRIBUTION |
| CONQUER CANCER FOUNDATION OF ASCO | ||||||||
| 2318 MILL RD SUITE 800 | ALEXANDRIA | VA | 22314 | 311667995 | 501(C)(3) | $3,566,050 | $0 | CONTRIBUTION |
| DANA FARBER CANCER INSTITUTE | ||||||||
| 10 BROOKLINE PLACE W | BROOKLINE | MA | 02445 | 042263040 | 501(C)(3) | $41,430 | $0 | CONTRIBUTION |
| DUKE UNIVERSITY | ||||||||
| 2200 W MAIN ST SUITE 820 | DURHAM | NC | 27705 | 560532129 | 501(C)(3) | $25,000 | $0 | CONTRIBUTION |
| FRIENDS OF CANCER RESEARCH | ||||||||
| 1800 M STREET NW SUITE 1050 SOUTH | WASHINGTON | DC | 20036 | 521983273 | 501(C)(3) | $25,000 | $0 | CONTRIBUTION |
| HEALTH VOLUNTEERS OVERSEAS | ||||||||
| 1900 L STREET NW SUITE 310 | WASHINGTON | DC | 20036 | 521485477 | 501(C)(3) | $10,000 | $0 | CONTRIBUTION |
| NATIONAL COALITION FOR CANCER SURVIVORSHIP | ||||||||
| 8455 COLESVILLE RD SUITE 930 | SILVER SPRINGS | MD | 20910 | 850357897 | 501(C)(3) | $10,000 | $0 | CONTRIBUTION |
| SARAH CANON RESEARCH INSTITUTE OF HCA HEALTHCARE | ||||||||
| 3322 WEST END AVE SUITE 900 | NASHVILLE | TN | 37203 | 201557751 | N/A | $60,000 | $0 | CONTRIBUTION |
| UNIVERSITY OF CHICAGO | ||||||||
| 5801 ELLIS AVE | CHICAGO | IL | 60637 | 362177139 | 501(C)(3) | $163,600 | $0 | CONTRIBUTION |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 10 | Total501c3OrgCnt |
| Total Other Org | 2 | TotalOtherOrgCnt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, LINE 2: | FormAndLineReferenceDesc |
| Explanation | ASCO PROVIDES ASSISTANCE TO ORGANIZATIONS THAT SERVE THE CANCER CARE COMMUNITY. THE MAJORITY OF THESE GRANTS ARE MADE TO OTHER 501(C)(3) ORGANIZATIONS. GRANTS MADE TO NON-501(C)(3) ORGANIZATIONS ARE MADE PURSUANT TO A WRITTEN AGREEMENT THAT REQUIRED THE GRANT FUNDS TO BE USED FOR SPECIFIC EDUCATIONAL AND CHARITABLE PROJECTS, THAT THE GRANTEE RETURN ANY PORTION OF THE GRANT FUNDS THAT WERE NOT USED FOR SUCH PROJECTS, AND THAT THE GRANTEE PROVIDE ANNUAL NARRATIVE AND FINANCIAL REPORTS TO ASCO REGARDING GRANTEE'S USE OF THE GRANT FUNDS. | ExplanationTxt |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Compensation Committee | Yes (X) | CompensationCommitteeInd |
| Independent Consultant | Yes (X) | IndependentConsultantInd |
| Form990 Of Other Organizations | Yes (X) | Form990OfOtherOrganizationsInd |
| Compensation Survey | Yes (X) | CompensationSurveyInd |
| Board Or Committee Approval | Yes (X) | BoardOrCommitteeApprovalInd |
| Severance Payment | 0 | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | 0 | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | 0 | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | 0 | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | 0 | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | 0 | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | 0 | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | Yes (1) | AnyNonFixedPaymentsInd |
| Initial Contract Exception | 0 | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (17 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CLIFFORD HUDIS MD | ||||||||||||||
| CHIEF EXECUTIVE OFFICER | $886,337 | $0 | $1,200 | $0 | $1,188 | $0 | $21,750 | $0 | $0 | $0 | $910,475 | $0 | $0 | $0 |
| DINA MICHELS ESQ | ||||||||||||||
| SECRETARY, EVP & COO | $591,777 | $0 | $1,700 | $0 | $1,851 | $0 | $21,750 | $0 | $18,529 | $0 | $635,607 | $0 | $0 | $0 |
| JULIE R GRALOW MD | ||||||||||||||
| EVP & CHIEF MEDICAL OFFICER | $481,922 | $0 | $1,000 | $0 | $1,005 | $0 | $21,750 | $0 | $15,483 | $0 | $521,160 | $0 | $0 | $0 |
| CHRISTOPHER MERLAN | ||||||||||||||
| EVP & CHIEF DIGITAL OFFICE | $420,584 | $0 | $1,000 | $0 | $414 | $0 | $21,750 | $0 | $25,594 | $0 | $469,342 | $0 | $0 | $0 |
| NANCY DALY MS MPH | ||||||||||||||
| EVP & CEO CONQUER CANCER F | $413,369 | $0 | $1,000 | $0 | $1,188 | $0 | $21,750 | $0 | $24,437 | $0 | $461,744 | $0 | $0 | $0 |
| LINDA JENSEN CPA | ||||||||||||||
| EVP AND CFO | $404,497 | $0 | $1,200 | $0 | $2,351 | $0 | $21,750 | $0 | $20,809 | $0 | $450,607 | $0 | $0 | $0 |
| JAMIE VON ROENN MD | ||||||||||||||
| VP, EDU., SCIENCE & PROF. | $399,211 | $0 | $1,000 | $0 | $9,903 | $0 | $21,750 | $0 | $8,795 | $0 | $440,659 | $0 | $0 | $0 |
| STEPHEN GRUBBS MD | ||||||||||||||
| VICE PRESIDENT, CARE DELIV | $396,910 | $0 | $1,000 | $0 | $2,286 | $0 | $21,750 | $0 | $17,671 | $0 | $439,617 | $0 | $0 | $0 |
| SEAN KHOZIN MD | ||||||||||||||
| EVP & CEO OF CANCERLINQ | $408,571 | $0 | $1,000 | $0 | $228 | $0 | $21,750 | $0 | $7,085 | $0 | $438,634 | $0 | $0 | $0 |
| ROBERT MILLER MD | ||||||||||||||
| MEDICAL DIRECTOR, CANCERLI | $357,672 | $0 | $2,000 | $0 | $1,927 | $0 | $21,750 | $0 | $25,113 | $0 | $408,462 | $0 | $0 | $0 |
| CARMEN JACKSON | ||||||||||||||
| CHIEF OF OPERATIONS, CLQ | $283,096 | $0 | $22,000 | $0 | $180 | $0 | $21,564 | $0 | $25,594 | $0 | $352,434 | $0 | $0 | $0 |
| DEBORAH KAMIN RN PHD | ||||||||||||||
| VP POLICY & ADVOCAY | $303,609 | $0 | $1,000 | $0 | $3,708 | $0 | $21,750 | $0 | $21,687 | $0 | $351,754 | $0 | $0 | $0 |
| ANIL NAIR | ||||||||||||||
| CHIEF TECHNOLOGY OFFICER, | $276,701 | $0 | $22,000 | $0 | $774 | $0 | $20,962 | $0 | $16,286 | $0 | $336,723 | $0 | $0 | $0 |
| KRISTIN LUDWIG | ||||||||||||||
| VP, MARKETING & COMMUNICAT | $310,001 | $0 | $1,000 | $0 | $774 | $0 | $21,750 | $0 | $0 | $0 | $333,525 | $0 | $0 | $0 |
| BARTON LAWYER | ||||||||||||||
| VICE PRESIDENT - IT | $248,584 | $0 | $1,000 | $0 | $414 | $0 | $19,125 | $0 | $27,593 | $0 | $296,716 | $0 | $0 | $0 |
| AMANDA DAVIS-AITKEN | ||||||||||||||
| VICE PRESIDENT, MEETING SV | $259,211 | $0 | $2,000 | $0 | $180 | $0 | $19,500 | $0 | $8,479 | $0 | $289,370 | $0 | $0 | $0 |
| ANGELA COCHRAN | ||||||||||||||
| VP, PUBLISHING | $247,210 | $0 | $1,000 | $0 | $270 | $0 | $18,750 | $0 | $16,286 | $0 | $283,516 | $0 | $0 | $0 |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, LINE 7 | FormAndLineReferenceDesc |
| Explanation | THE ORGANIZATION HAS A DISCRETIONARY BONUS PLAN UNDER WHICH SELECTED EMPLOYEES, INCLUDING OFFICERS, KEY EMPLOYEES, AND OTHER EMPLOYEES ARE COMPENSATED BASED ON PERFORMANCE AND THE ACHIEVEMENT OF ORGANIZATIONAL GOALS. BONUSES FOR KEY EMPLOYEES AND HIGHEST COMPENSATED EMPLOYEES ARE APPROVED BY THE CHIEF EXECUTIVE OFFICER WITH REVIEW AND APPROVAL BY THE COMPENSATION COMMITTEE OF THE BOARD, WHERE APPROPRIATE. IN ADDITION, THE ORGANIZATION AWARDS MODEST AMOUNTS TO EMPLOYEES ON ACHIEVING CERTAIN NUMBER OF YEARS OF EMPLOYMENT. FROM TIME TO TIME, THE ORGANIZATION MAY MAKE STANDARD PAYMENTS TO ITS EMPLOYEES IN GOOD STANDING WITH MINIMUM TIME OF EMPLOYMENT TO RECOGNIZE EFFORT AND COMMITMENT TO THE ORGANIZATION'S GOALS IN THAT YEAR. | ExplanationTxt |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (17 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| FORM 990, PART III, LINE 1 | ASCO IS A PROFESSIONAL ONCOLOGY SOCIETY COMMITTED TO CONQUERING CANCER THROUGH RESEARCH, EDUCATION, AND PROMOTION OF THE HIGHEST QUALITY, EQUITABLE PATIENT CARE. ASCO'S VISION IS A WORLD WHERE CANCER IS PREVENTED OR CURED, AND EVERY SURVIVOR IS HEALTHY. ASCO PROMOTES AND PROVIDES FOR: - LIFELONG LEARNING FOR ONCOLOGY PROFESSIONALS, - CANCER RESEARCH, - AN IMPROVED ENVIRONMENT FOR ONCOLOGY PRACTICE, - ACCESS TO QUALITY CANCER CARE, - A GLOBAL NETWORK OF ONCOLOGY EXPERTISE, AND - EDUCATED AND INFORMED PATIENTS WITH CANCER. |
| FORM 990, PART III, LINE 4A: | QUALITY OF CARE: ASCO, THROUGH COLLECTION OF ONCOLOGY PRACTICE CARE DELIVERY METRICS, DEVELOPS INSIGHTS TO IMPROVE THE QUALITY AND EQUITY OF ONCOLOGY CARE DELIVERY. ASCO ALSO PRODUCES EVIDENCE-BASED GUIDELINES, QUALITY MEASURES AND DEVELOPS STANDARDS FOR QUALITY ONCOLOGY CARE, AND PROVIDES TRAINING IN QUALITY CARE IMPROVEMENT. CANCERLINQ'S BIG-DATA PLATFORM DELIVERS VALUABLE INSIGHTS AND TOOLS TO PARTICIPATING PRACTICES AND DE-IDENTIFIED DATA FOR CANCER TREATMENT RESEARCH. THE CANCERLINQ DATABASE, WHICH INCLUDES INFORMATION FROM MILLIONS OF CANCER PATIENT CARE RECORDS, REFLECTS CANCER CARE IN ALL ITS REAL-WORLD VARIABILITY, ALLOWING CLINICIANS TO LEARN FROM THE EXPERIENCE OF EVERY PATIENT. QUALITY ONCOLOGY PRACTICE INITIATIVE (QOPI). A QUALITY SELF ASSESSMENT AND IMPROVEMENT PROGRAM FOR OUTPATIENT MEDICAL ONCOLOGY AND HEMATOLOGY-ONCOLOGY PRACTICES: QOPI PROVIDES A WEB-BASED DATA COLLECTION TOOL THAT ALLOWS PRACTICE STAFF TO 1) REPORT ON VARIOUS CANCER CARE QUALITY MEASURES, 2) RECEIVE ANALYZED DATA ON PRACTICE PERFORMANCE, AND 3) COMPARE PERFORMANCE AGAINST THEIR PEERS FOR DATA-DRIVEN IMPROVEMENT ACTIVITIES. QUALITY TRAINING PROGRAM. ASCO'S QUALITY TRAINING PROGRAM IS DESIGNED TO EDUCATE AND TRAIN PRACTICES THE TECHNIQUES OF CLINICAL CARE AND OPERATIONAL PERFORMANCE QUALITY IMPROVEMENT. |
| FORM 990, PART III, LINE 4B: | SCIENTIFIC AND MEDICAL EDUCATION: ASCO PROVIDES SCIENTIFIC AND EDUCATIONAL PROGRAMS AND CONTENT ON A BROAD RANGE OF ONCOLOGY-RELATED TOPICS IN A VARIETY OF FORMATS. WORKING WITH VOLUNTEER ASCO MEMBERS, ASCO PLANS AND PRESENTS MEETINGS ON THE LATEST CANCER RESEARCH AND EDUCATIONAL SESSIONS HIGHLIGHTING ADVANCES IN RESEARCH AND ONCOLOGY CARE. ASCO'S PROGRAMS ARE DESIGNED TO SERVE THE DIVERSE NEEDS OF ONCOLOGY PRACTITIONERS WORLDWIDE, ASSISTING THEM IN DELIVERING HIGH QUALITY CANCER CARE AND CONDUCTING CLINICAL RESEARCH THROUGH THE CONTINUUM OF THEIR CAREERS. PROGRAMS ADDRESS ONGOING RESEARCH AND THE MODERN- DAY PRACTICE OF ONCOLOGY FOR THE COMMUNITY OF MULTIDISCIPLINARY ONCOLOGY CARE PROVIDERS. ASCO ANNUAL MEETING IS THE WORLD'S PREMIER SCIENTIFIC AND EDUCATIONAL CLINICAL ONCOLOGY MEETING. ASCO ALSO SPONSORS OR CO-SPONSORS THEMATIC MEETINGS (FOCUSING ON SUBSPECIALTY AREAS), WHICH PROVIDE OPPORTUNITIES FOR FOCUSED EDUCATIONAL AND SCIENTIFIC SESSIONS ON SPECIFIC TYPES OF CANCERS. HIGHLIGHTS OF THE 2021 VIRTUAL ANNUAL MEETING INCLUDE OVER 5,000 SCIENTIFIC ABSTRACTS FOR NEARLY 33,000 ATTENDEES. THE GASTROINTESTINAL CANCERS AND THE GENITOURINARY CANCERS SYMPOSIA COVERED 751 AND 580 ABSTRACTS, RESPECTIVELY, FOR 4,100 AND 5,150 ATTENDEES. CONTENT IS MAINTAINED DIGITALLY AND MADE ACCESSIBLE. DUE TO THE COVID-19 PANDEMIC, ASCO'S MEETINGS WERE PRESENTED VIRTUALLY THROUGH JUNE, 2021. THESE MEETINGS ARE NOW PRESENTED IN BOTH A VIRTUAL AND IN-PERSON (HYBRID) FORMAT. THE HYBRID FORMAT HAS ENABLED PARTICIPATION FROM A LARGER AND MORE DIVERSE DOMESTIC AND INTERNATIONAL AUDIENCE. ASCO'S SCIENTIFIC AND EDUCATION PROGRAMS ALSO INCLUDE DIGITAL EDUCATION PROGRAMS, PROFESSIONAL DEVELOPMENT ACTIVITIES, AND LICENSING PROGRAMS THAT ALLOW ASCO TO BROADLY DELIVER ITS MATERIALS AND EDUCATION FOR THE ENTIRE SPECTRUM OF PROFESSIONALS WORKING IN ONCOLOGY CARE. IN 2021, ASCO HELD THE STATUS OF JOINT ACCREDITATION FROM THE ACCREDITATION COUNCIL FOR CONTINUING MEDICAL EDUCATION, ALLOWING ASCO TO PROVIDE CONTINUING EDUCATION CREDIT FOR PHYSICIANS, NURSES AND PHARMACISTS. |
| FORM 990, PART III, LINE 4C: | SCIENTIFIC PUBLICATIONS: ASCO PRODUCES A NUMBER OF PROFESSIONAL PUBLICATIONS AND GENERAL PUBLICATIONS FOCUSED ON CLINICAL ONCOLOGY. ASCO PUBLISHES HIGH-QUALITY, PEER-REVIEWED SCIENTIFIC PAPERS IN ITS JOURNALS: - JOURNAL OF CLINICAL ONCOLOGY (JCO) IS A HIGHLY REGARDED JOURNAL PUBLISHING SCIENTIFIC MANUSCRIPTS AND ARTICLES ON SIGNIFICANT CLINICAL ONCOLOGY RESEARCH IN PRINT AND ELECTRONIC FORMATS. JCO IS MAILED THREE A TIMES A MONTH TO OVER 17,000 ASCO MEMBERS. OVER 3,000 GLOBAL INSTITUTIONS SUBSCRIBE TO THE PUBLICATION, PRINT AND ONLINE. - JCO ONCOLOGY PRACTICE (JCO OP) PUBLISHES ORIGINAL RESEARCH AND INSIGHTS TO KEEP ONCOLOGY PRACTICES CURRENT ON CHANGES AND CHALLENGES INHERENT IN DELIVERING EQUITABLE, HIGH-QUALITY ONCOLOGY CARE WITH AN EVOLVING VALUE-BASED LENS. ALL CONTENT DEALING WITH UNDERSTANDING THE PROVISION OF CARE - THE MECHANICS OF PRACTICE, CARE DELIVERY, QUALITY IMPROVEMENT, VALUE, AND EQUITY - IS THE PURVIEW OF JCO OP. JCO OP ALSO ADDRESSES AN EXPRESSED NEED BY PRACTICING PHYSICIANS TO HAVE COMPRESSED, EXPERT OPINION ADDRESSING COMMON CLINICAL PROBLEMS WITH PERSPECTIVES BY DISEASE EXPERTS. JCO OP MAILS MONTHLY TO APPROXIMATELY 24,000 ASCO MEMBERS AS WELL AS AFFILIATED MEDICAL PROFESSIONALS. - JCO GLOBAL ONCOLOGY (JCO GO) IS AN ONLINE-ONLY, OPEN ACCESS JOURNAL FOCUSING ON CANCER CARE, RESEARCH, AND CARE DELIVERY ISSUES UNIQUE TO COUNTRIES AND SETTINGS WITH LIMITED HEALTHCARE RESOURCES. - JCO CLINICAL CANCER INFORMATICS (JCO CCI) IS AN ONLINE-ONLY INTERDISCIPLINARY JOURNAL THAT PUBLISHES CLINICALLY RELEVANT RESEARCH BASED ON BIOMEDICAL INFORMATICS METHODS AND PROCESSES APPLIED TO CANCER-RELATED DATA, INFORMATION, AND IMAGES. - JCO PRECISION ONCOLOGY (JCO PO) IS AN ONLINE-ONLY JOURNAL PUBLISHING ORIGINAL RESEARCH, REPORTS, OPINIONS, AND REVIEWS THAT ADVANCE THE SCIENCE AND PRACTICE OF PRECISION ONCOLOGY AND DEFINES GENOMICS-DRIVEN CLINICAL CARE OF PATIENTS WITH CANCER. ASCO DAILY NEWS IS THE OFFICIAL CONFERENCE REPORT OF ASCO, WHICH PROVIDES SCIENTIFIC AND EDUCATIONAL SUMMARIES FROM ONCOLOGY CONFERENCES. IT IS MAILED TO OVER 10,000 ASCO MEETING ATTENDEES FOR THE ASCO ANNUAL MEETING AND THEMATIC MEETINGS. THE ONLINE VERSION PUBLISHES CONTENT YEAR-ROUND. ASCO ALSO PROVIDES CONTENT AND DISTRIBUTION LISTS FOR TRADE PUBLICATIONS. WHILE NOT OWNED OR PUBLISHED BY ASCO, THE PUBLICATIONS COVER NEWS AND INFORMATION OF INTEREST TO THE PROFESSIONAL ONCOLOGY COMMUNITY. |
| FORM 990, PART VI, SECTION A, LINE 1A | AS OF DECEMBER 31, 2021, THE BOARD OF DIRECTORS OF ASCO INCLUDED 19 MEMBERS WITH THE RIGHT TO VOTE ON ALL MATTERS THAT COME BEFORE THE BOARD OF DIRECTORS. THE BOARD OF DIRECTORS ALSO INCLUDED ONE EX-OFFICIO DIRECTOR WITHOUT THE RIGHT TO VOTE, WHO WAS THE CHIEF EXECUTIVE OFFICER OF ASCO (CEO). DURING THE REPORTING YEAR, THE BOARD OF DIRECTORS DELEGATED AUTHORITY TO ACT ON ITS BEHALF TO THE EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS, CONSISTENT WITH ASCO'S BYLAWS. PURSUANT TO THE BYLAWS, THE VOTING MEMBERS OF THE EXECUTIVE COMMITTEE ARE THE PRESIDENT, THE PRESIDENT-ELECT, THE CHAIR, THE PAST PRESIDENT, THE TREASURER, THE TREASURER-ELECT, AND THOSE DIRECTORS SERVING THE FINAL YEAR OF THEIR PRESENT TERMS. THE CEO IS A NON-VOTING MEMBER OF THE EXECUTIVE COMMITTEE. ALL EXECUTIVE COMMITTEE MEMBERS ARE MEMBERS OF ASCO'S BOARD OF DIRECTORS. THE SCOPE OF THE EXECUTIVE COMMITTEE'S AUTHORITY IS ESTABLISHED BY ASCO'S BYLAWS, WHICH PROVIDE THAT, EXCEPT TO THE EXTENT SPECIFICALLY PROHIBITED BY RESOLUTION OF THE BOARD OF DIRECTORS OR OTHERWISE PROHIBITED BY LAW, THE EXECUTIVE COMMITTEE OF THE BOARD IS EMPOWERED TO MAKE AND IMPLEMENT MAJOR DECISIONS BETWEEN BOARD MEETINGS, AND IT MAY ACT ON ITEMS REQUIRING ACTION PRIOR TO THE NEXT ANNOUNCED MEETING OF THE BOARD OF DIRECTORS. ALL ACTIONS OF THE EXECUTIVE COMMITTEE ARE REPORTED TO THE BOARD OF DIRECTORS AT THE NEXT MEETING OF THE BOARD OF DIRECTORS IMMEDIATELY FOLLOWING THE ACTION TAKEN BY THE EXECUTIVE COMMITTEE, CONSISTENT WITH ASCO'S BYLAWS. |
| FORM 990, PART VI, SECTION A, LINE 2 | DR. LORI J. PIERCE, FASTRO, FASCO, SERVED AS PRESIDENT AND CHAIR OF ASCO AND AS A MEMBER OF THE ASCO BOARD OF DIRECTORS DURING 2021. SHE ALSO SERVES AS A PROFESSOR OF THE DEPARTMENT OF RADIATION ONCOLOGY AT THE UNIVERSITY OF MICHIGAN, AND AS VICE PROVOST FOR ACADEMIC AND FACULTY AFFAIRS. DR. RESHMA JAGSI, FASTRO, FASCO, SERVED AS A MEMBER OF THE ASCO BOARD OF DIRECTORS DURING 2021. SHE ALSO SERVES AS DEPUTY CHAIR OF RADIATION ONCOLOGY AT THE UNIVERSITY OF MICHIGAN. DR. CLIFFORD HUDIS, LINDA JENSEN, AND MELISSA TAI WERE ALL EMPLOYED BY THE ASSOCIATION'S AFFILIATE, THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (THE SOCIETY), A SECTION 501(C)(3) PUBLIC CHARITY. DR. HUDIS IS THE CHIEF EXECUTIVE OFFICER OF THE SOCIETY AND MS. JENSEN IS THE CHIEF FINANCIAL OFFICER AND EXECUTIVE VICE PRESIDENT OF THE SOCIETY. DR. MONICA BERTAGNOLLI, DR. HOWARD BURRIS, III, DR. ERIC SMALL, DR. A. WILLIAM BLACKSTOCK, DR. LEE ELLIS, DR. LAURIE GASPAR, DR. RESHMA JAGSI, DR. MICHAEL KOSTY, DR. ELIZABETH MITTENDORF, DR. TONY MOK, DR. LORI PIERCE, DR. EVERETT VOKES, DR. TRACEY WEISBERG, AND DR. ERIC WINER ALL SERVED AS VOTING MEMBERS OF THE SOCIETY'S BOARD OF DIRECTORS DURING THE TAX YEAR. IN ADDITION, DURING THE TAX YEAR, DR. BERTAGNOLLI SERVED AS PAST PRESIDENT OF THE SOCIETY, DR. BURRIS SERVED AS CHAIR OF THE BOARD AND PAST PRESIDENT OF THE SOCIETY, DR. PIERCE SERVED AS PRESIDENT AND CHAIR OF THE BOARD OF THE SOCIETY, DR. VOKES SERVED AS PRESIDENT-ELECT AND PRESIDENT OF THE SOCIETY, DR. WINER SERVED AS PRESIDENT-ELECT OF THE SOCIETY, DR. GASPAR SERVED AS TREASURER OF THE SOCIETY, AND DR. MITTENDORF SERVED AS TREASURER-ELECT OF THE SOCIETY. |
| FORM 990, PART VI, SECTION A, LINE 4 | THE ASCO MEMBERSHIP APPROVED AMENDMENTS TO ASCO'S CERTIFICATE OF INCORPORATION AND BYLAWS THAT BECAME EFFECTIVE IN 2021. THE CERTIFICATE OF INCORPORATION WAS AMENDED TO PERMIT THE VOTING MEMBERS TO TAKE ACTION BY WRITTEN CONSENT IF (1) NO FEWER THAN 100 MEMBERS ELIGIBLE TO VOTE CONSENT TO SUCH ACTION IN WRITING OR ELECTRONICALLY, AND (2) SUCH ACTION IS APPROVED BY THE PROPORTION OF VOTES CAST BY MEMBERS ELIGIBLE TO VOTE AS WOULD BE REQUIRED TO APPROVE SUCH ACTION IF THE VOTES WERE CAST AT A MEETING OF THE MEMBERS. THE SIGNIFICANT AMENDMENTS TO THE BYLAWS INCLUDE THE FOLLOWING: ENHANCED BENEFITS FOR ALL MEMBERS WITH DOCTORAL-LEVEL DEGREES. PREVIOUSLY, THE BYLAWS MADE REFERENCE TO SPECIFIC CLASSES OF MEMBERS, SPECIFYING THAT "FULL MEMBERS" WERE PHYSICIANS ANDSOMEDOCTORAL LEVEL PROVIDERS, AND"OTHER MEMBERS" WERE MEMBER CLASSES AS DEFINED IN THE POLICY ADOPTED BY THE ASCO AND THE ASSOCIATION BOARDS OF DIRECTORS. UNDER THE PREVIOUS BYLAWS AND THE ASCO MEMBERSHIP POLICY, FULL MEMBERS AND SOME OF THE CATEGORIES OF OTHER MEMBERS HAD VOTING RIGHTS AND WERE ELIGIBLE TO SERVE ON THE ASCO BOARD OF DIRECTORS, ON THE ASCO NOMINATING COMMITTEE, OR AS ASCO ELECTED OFFICERS. TOGETHER, THOSE CATEGORIES REPRESENTED APPROXIMATELY 57% OF THE TOTAL ASCO MEMBERSHIP. THE AMENDMENTS REPLACED THE EXISTING CONCEPT OF "FULL MEMBERS AND "OTHER MEMBERS" WITH THE CONCEPT OF "MEMBERS AND "VOTING MEMBERS". UNDER THE AMENDED BYLAWS, "MEMBERS" REFERS TO ALL ASCO MEMBERS. "VOTING MEMBERS" REFERS TO THOSE MEMBERS WHO HAVE VOTING RIGHTS, AND ARE ELIGIBLE TO SERVE ON THE ASCO BOARD OF DIRECTORS, ON THE ASCO NOMINATING COMMITTEE, OR AS ASCO ELECTED OFFICERS. THE AMENDMENTS ALSO EXPANDED THE NUMBER OF ASCO MEMBERS WHO HAD THESE RIGHTS ANY ONCOLOGY MEDICAL PROFESSIONAL WITH A DOCTORAL-LEVEL DEGREE MAY BE A VOTING MEMBER. THE CHANGES WERE PROJECTED TO PERMIT APPROXIMATELY 83% OF TOTAL ASCO MEMBERSHIP TO HAVE VOTING RIGHTS AND BE ELIGIBLE TO SERVE ON THE BOARD OF DIRECTORS, ON THE NOMINATING COMMITTEE, OR AS AN ELECTED OFFICER. EXPANDED DIVERSITY ON THE BOARD OF DIRECTORS. PREVIOUSLY, THE BYLAWS REQUIRED THAT ALL MEMBERS OF THE BOARD OF DIRECTORS BE ONCOLOGISTS, WHO HAD TO BE PHYSICIANS. THE AMENDMENTS TO THE BYLAWS PERMIT THOSE BOARD MEMBERS WHO SIT IN "UNDESIGNATED" BOARD SEATS TO BE ANY ONCOLOGY PROFESSIONAL WITH A DOCTORAL- LEVEL DEGREE (NOT LIMITED TO PHYSICIANS). UNCONTESTED PRESIDENTIAL ELECTION. PREVIOUSLY, THE ASCO NOMINATING COMMITTEE SELECTED TWO NOMINEES EACH YEAR FOR PRESIDENT-ELECT THAT WERE THEN PRESENTED TO THE ASCO MEMBERSHIP FOR VOTE. UNDER THE APPROVED AMENDMENTS, EACH YEAR THE NOMINATING COMMITTEE WILL SELECT TWO CANDIDATES FOR THE ROLE OF PRESIDENT-ELECT, WHO ARE SUBMITTED TO THE ASCO BOARD OF DIRECTORS, WHICH THEN SELECTS THE BEST CANDIDATE FROM THE TWO CHOICES. THAT CANDIDATE IS PRESENTED TO THE ASCO MEMBERS FOR ELECTION THE ASCO VOTING MEMBERS MAY VOTE FOR THAT CANDIDATE, WRITE IN AN ALTERNATE CANDIDATE, OR ABSTAIN FROM VOTING. THIS CHANGE WAS INTENDED TO PERMIT THE NOMINATING COMMITTEE TO BETTER SUPPORT DIVERSITY IN THE ROLE OF PRESIDENT-ELECT FROM YEAR TO YEAR, WITH THE EXPECTATION THAT OVER THE LONG TERM, THE ASCO PRESIDENCY WILL REFLECT THE DIVERSITY OF THE MEMBERSHIP IN EVERY WAY: SPECIALTY, PROFESSIONAL SETTING, DEMOGRAPHICS, ANDOTHER CHARACTERISTICS. CONTINUITY IN THE ROLE OF TREASURER. PREVIOUSLY, THE ROLE OF TREASURER WAS TREATED AS A UNIQUE SEAT ON THE BOARD OF DIRECTORS, WITH ASCO MEMBERS VOTING FOR A CANDIDATE TO SERVE AS TREASURER EVERY FOUR YEARS. UNDER THE AMENDED BYLAWS, THE TREASURER-ELECT WILL BE ELECTED EACH YEAR FROM AMONG THE SERVING BOARD MEMBERS BY THE BOARD OF DIRECTORS. THE TREASURER-ELECT WILL SERVE A ONE-YEAR TERM, AND THEN SERVE A ONE-YEAR TERM AS TREASURER. THIS CHANGE WAS INTENDED TO ENSURE THAT THE ASCO TREASURER WOULD ALREADY HAVE EXPERIENCE WITH SOCIETY OPERATIONS FROM THEIR SERVICE ON THE BOARD AND AS TREASURER-ELECT BEFORE SERVING AS TREASURER. COMPOSITION OF NOMINATING COMMITTEE. PREVIOUSLY, THE NOMINATING COMMITTEE WAS COMPOSED OF THE ASCO PRESIDENT, CHAIR, AND THOSE OTHER NOMINATING COMMITTEE MEMBERS THAT WERE ELECTED BY THE ASCO MEMBERS. UNDER THE AMENDED BYLAWS, THE ASCO PRESIDENT-ELECT AND PAST PRESIDENT HAVE BEEN ADDED TO THE NOMINATING COMMITTEE. APPROVAL OF BYLAWS AMENDMENTS. PREVIOUSLY, PROPOSED AMENDMENTS HAD TO BE APPROVED BY A TWO-THIRDS VOTE OF THE ASCO MEMBERS ELIGIBLE TO VOTE TO BECOME EFFECTIVE. UNDER THE AMENDED BYLAWS, PROPOSED AMENDMENTS TO THE BYLAWS MUST BE APPROVED BY THE VOTE OF A MAJORITY OF THE VOTES CAST BY VOTING-ELIGIBLE MEMBERS TO BECOME EFFECTIVE. |
| FORM 990, PART VI, SECTION A, LINE 6 | VOTING MEMBERS. ALL ASCO MEMBERS MUST BE ONCOLOGY MEDICAL PROFESSIONALS, DEFINED AS INDIVIDUALS WHO MEET ANY OF THE FOLLOWING QUALIFICATIONS: (1) INDIVIDUALS WHOSE PROFESSIONAL CREDENTIALS AND ACTIVITIES INVOLVE CANCER PATIENT CARE AND/OR RESEARCH, EDUCATION, OR ADVOCACY IN THE BIOLOGY, DIAGNOSIS, PREVENTION OR TREATMENT OF HUMAN CANCER; (2) INDIVIDUALS WHO ARE RETIRED FROM PROFESSIONAL ACTIVITIES, BUT WHOSE PROFESSIONAL ACTIVITIES PRIOR TO RETIREMENT INCLUDED THOSE SET FORTH ABOVE; (3) INDIVIDUALS WHO ARE STUDENTS TRAINING TO BE PROFESSIONALS DESCRIBED ABOVE. VOTING MEMBERS ARE ONCOLOGY MEDICAL PROFESSIONALS WHO HAVE BEEN AWARDED AND HOLD THE DEGREE OF DOCTOR OF MEDICINE, DOCTOR OF OSTEOPATHY, DOCTOR OF PHILOSOPHY, DOCTOR OF PHARMACY, DOCTOR OF MEDICAL SCIENCE, DOCTOR OF NURSING SCIENCE, DOCTOR OF NURSING PRACTICE, OR EQUIVALENT DOCTORAL-LEVEL DEGREE AS DETERMINED FROM TIME TO TIME BY ASCO AND THE ASSOCIATION. ONLY VOTING MEMBERS ARE ELIGIBLE TO VOTE OR SERVE ON THE BOARD OF DIRECTORS, ON THE NOMINATING COMMITTEE, OR AS ELECTED OFFICERS. |
| FORM 990, PART VI, SECTION A, LINE 7A | VOTING MEMBERS OF ASCO ELECT ALL VOTING MEMBERS OF THE ASCO BOARD OF DIRECTORS. |
| FORM 990, PART VI, SECTION A, LINE 7B | ASCO'S CERTIFICATE OF INCORPORATION MAY ONLY BE AMENDED UPON THE VOTE OF THE MEMBERS ENTITLED TO VOTE, AND THE BYLAWS MAY ONLY BE AMENDED, AND DISSOLUTION OF THE CORPORATION MAY ONLY BE APPROVED WITH THE APPROVAL OF BOTH THE BOARD OF DIRECTORS AND VOTING MEMBERS OF ASCO. |
| FORM 990, PART VI, SECTION B, LINE 11B | AN ELECTRONIC COPY OF THE FINAL FORM WAS SENT, THROUGH A SECURE SITE, TO EACH MEMBER OF THE BOARD OF DIRECTORS, AND WAS REVIEWED BY THE EXECUTIVE VICE PRESIDENT & CHIEF FINANCIAL OFFICER; THE CHIEF EXECUTIVE OFFICER; AND THE EXECUTIVE VICE PRESIDENT & CHIEF OPERATING OFFICER & CHIEF LEGAL OFFICER PRIOR TO FILING. |
| FORM 990, PART VI, SECTION B, LINE 12C | ASCO MAINTAINS A NUMBER OF WRITTEN CONFLICTS OF INTEREST POLICIES AND STANDARDS REGARDING THE DISCLOSURE AND MANAGEMENT OF CONFLICTS OF INTEREST. THESE POLICIES AND STANDARDS COVER ALL ASCO MEMBERS AND EMPLOYEES, DIRECTORS, OFFICERS, COMMITTEE MEMBERS, AND CERTAIN FAMILY MEMBERS (E.G. SPOUSE, DEPENDENT CHILDREN). COVERED INDIVIDUALS ARE ASKED TO DISCLOSE FINANCIAL INTERESTS IN OR OTHER RELATIONSHIPS WITH ENTITIES THAT HAVE RELEVANT COMMERCIAL INTERESTS, INCLUDING EMPLOYMENT OR LEADERSHIP POSITIONS, CONSULTANT OR ADVISORY ROLES, STOCK OWNERSHIP, HONORARIA, RESEARCH FUNDING, AND SERVICE AS AN EXPERT WITNESS. OFFICERS, DIRECTORS AND KEY EMPLOYEES ARE ALSO REQUIRED TO DISCLOSE SERVICE AS AN OFFICER, DIRECTOR, OR TRUSTEE OF ANY OTHER PROFESSIONAL OR ADVOCACY ORGANIZATION RELATING TO SCIENCE OR HEALTH CARE. COMPLETION OF A DISCLOSURE FORM IS REQUIRED AT THE INITIATION OF SERVICE AND UPDATED ANNUALLY THEREAFTER AND WHEN ANY MATERIAL CHANGES OCCUR. ASCO'S CONFLICT OF INTEREST POLICIES ARE INTENDED TO HELP GUIDE THE MANAGEMENT OF ACTUAL, POTENTIAL, AND PERCEIVED CONFLICTS OF INTEREST THROUGH DISCLOSURE OF FINANCIAL INTERESTS OR OTHER RELATIONSHIPS. WHERE THE NATURE AND EXTENT OF A FINANCIAL RELATIONSHIP SUGGEST DISCLOSURE IS NOT ADEQUATE TO MANAGE A REAL OR POTENTIAL CONFLICT, COVERED INDIVIDUALS ARE REQUIRED TO RECUSE THEMSELVES FROM DECISION MAKING. RECUSAL MAY BE SELF-SELECTED, OR MAY BE REQUESTED BY THE COMMITTEE CHAIR, OFFICER, OR EXECUTIVE-LEVEL STAFF MEMBERS. IN ADDITION, IF ASCO WERE TO CONTEMPLATE ENTERING INTO A TRANSACTION OR ARRANGEMENT THAT MIGHT BENEFIT THE PRIVATE INTEREST OF ANY INTERESTED PERSON (I.E. AN ASCO DIRECTOR, PRINCIPAL OFFICER, OR MEMBER OF AN ASCO COMMITTEE WITH BOARD DELEGATED POWERS WHO HAS A DIRECT OR INDIRECT FINANCIAL INTEREST IN THE TRANSACTION), IT MUST FOLLOW A SPECIFIC PROCEDURE TO MANAGE THE CONFLICT, INCLUDING CONSIDERING ALTERNATIVE TRANSACTIONS THAT WOULD NOT GIVE RISE TO A CONFLICT OF INTEREST. |
| FORM 990, PART VI, SECTION B, LINE 15 | COMPENSATION OF CHIEF EXECUTIVE OFFICER (CEO): THE DUTIES OF THE CEO OF ASCO INCLUDE SERVING AS: THE CEO OF ASCO, THE EXECUTIVE VICE CHAIR OF ASCO'S NON-PROFIT, 501(C)(3) TAX- EXEMPT RELATED ORGANIZATION, CONQUER CANCER FOUNDATION OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (CC); THE CEO OF ASCO'S NON-PROFIT, 501(C)(6) TAX-EXEMPT RELATED ORGANIZATION, ASCO ASSOCIATION (D/B/A ASSOCIATION FOR CLINICAL ONCOLOGY)(ASSOCIATION), THE PRESIDENT OF QOPI CERTIFICATION PROGRAM, LLC; THE PRESIDENT OF ASCO LEASING LLC, AND THE CHAIR OF THE BOARD OF GOVERNORS OF CANCERLINQ LLC. ALL ORGANIZATIONS LISTED ARE RELATED ORGANIZATIONS OF ASCO. THE WRITTEN EMPLOYMENT CONTRACT BETWEEN THE CEO AND ASCO ADDRESSES COMPENSATION OF THE CEO. THE COMPENSATION OF THE CEO WAS DETERMINED BY THE ASCO BOARD OF DIRECTORS, FOLLOWING THE REVIEW AND RECOMMENDATION OF THE BOARD COMPENSATION COMMITTEE. THE COMPENSATION COMMITTEE CONSULTED WITH INDEPENDENT LEGAL COUNSEL AND ITS INDEPENDENT COMPENSATION CONSULTANT. THE INDEPENDENT COMPENSATION CONSULTANT COLLECTED AND REPORTED ON COMPARABLE MARKET DATA (INCLUDING DATA ON COMPARABLE COMPENSATION FOR SIMILARLY QUALIFIED PERSONS IN FUNCTIONALLY COMPARABLE POSITIONS AT SIMILARLY SITUATED ORGANIZATIONS) AND PROVIDED ITS OPINION THAT THE COMPENSATION FOR THE CEO WAS REASONABLE. THE REVIEW, RECOMMENDATION, AND DETERMINATION OF THE CEO'S COMPENSATION BASED ON THE ABOVE-DESCRIBED PROCESS WAS MOST RECENTLY UNDERTAKEN IN 2021. THE COMPENSATION OF THE FOLLOWING POSITIONS WAS CONSIDERED AND APPROVED BY THE ASCO BOARD COMPENSATION COMMITTEE, AFTER RECEIVING THE RECOMMENDATION OF THE CEO AND AN INDEPENDENT COMPENSATION CONSULTANT. THE INDEPENDENT COMPENSATION CONSULTANT COLLECTED AND REPORTED ON COMPARABLE MARKET DATA (INCLUDING DATA ON COMPARABLE COMPENSATION FOR SIMILARLY QUALIFIED PERSONS IN FUNCTIONALLY COMPARABLE POSITIONS AT SIMILARLY SITUATED ORGANIZATIONS) AND PROVIDED ITS OPINION THAT THE COMPENSATION FOR EACH OF THE POSITIONS WAS REASONABLE. - EXECUTIVE VICE PRESIDENT & CHIEF OPERATING OFFICER & CHIEF LEGAL OFFICER & ASCO SECRETARY (EVP & COO): THE CONSIDERATION AND APPROVAL OF THE COMPENSATION OF THE EVP & COO BASED ON THE ABOVE DESCRIBED PROCESS WERE MOST RECENTLY UNDERTAKEN IN 2021. THE EVP & COO'S COMPENSATION WAS ALSO REVIEWED AND APPROVED BY THE BOARD OF DIRECTORS, AS REQUIRED UNDER STATE LAW. - EXECUTIVE VICE PRESIDENT AND CHIEF FINANCIAL OFFICER (EVP & CFO): THE CONSIDERATION AND APPROVAL OF THE COMPENSATION OF THE EVP & CFO BASED ON THE ABOVE-DESCRIBED PROCESS WERE MOST RECENTLY UNDERTAKEN IN 2021. - EXECUTIVE VICE PRESIDENT & CHIEF MEDICAL OFFICER (EVP & CMO): THE CONSIDERATION AND APPROVAL OF THE COMPENSATION OF THE EVP & CMO BASED ON THE ABOVE-DESCRIBED PROCESS WAS MOST RECENTLY UNDERTAKEN IN 2021. - EXECUTIVE VICE PRESIDENT & CHIEF DIGITAL OFFICER (EVP & CDO): THE CONSIDERATION AND APPROVAL OF THE COMPENSATION OF THE EVP & CDO BASED ON THE ABOVE-DESCRIBED PROCESS WERE MOST RECENTLY UNDERTAKEN IN 2021. - EXECUTIVE VICE PRESIDENT OF ASCO & CHIEF EXECUTIVE OFFICER OF THE CONQUER CANCER FOUNDATION OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (EVP & CC CEO): THE EVP & CC CEO IS AN EMPLOYEE OF ASCO. THE CONSIDERATION AND APPROVAL OF THE COMPENSATION OF THE EVP & CC CEO BASED ON THE ABOVE-DESCRIBED PROCESS WERE MOST RECENTLY UNDERTAKEN IN 2021. - EXECUTIVE VICE PRESIDENT OF ASCO & CHIEF EXECUTIVE OFFICER OF CANCERLINQ LLC (EVP & CLQ CEO): THE EVP & CLQ CEO IS AN EMPLOYEE OF ASCO. THE CONSIDERATION AND APPROVAL OF THE COMPENSATION OF THE EVP & CC CEO BASED ON THE ABOVE-DESCRIBED PROCESS WERE MOST RECENTLY UNDERTAKEN IN 2021. |
| FORM 990, PART VI, SECTION C, LINE 18 | ASCO'S GOVERNING DOCUMENTS ARE AVAILABLE TO THE PUBLIC FROM ASCO UPON REQUEST. ASCO'S CERTIFICATE OF INCORPORATION IS ALSO AVAILABLE TO THE PUBLIC THROUGH THE SECRETARY OF STATE OF NEW YORK. ASCO'S CONFLICT OF INTEREST POLICY IS POSTED ON ASCO'S WEBSITE AND IS AVAILABLE TO THE PUBLIC FROM ASCO UPON REQUEST. |
| FORM 990, PART VI, SECTION C, LINE 19 | ASCO'S GOVERNING DOCUMENTS ARE AVAILABLE TO THE PUBLIC FROM ASCO UPON REQUEST. ASCO'S CERTIFICATE OF INCORPORATION IS ALSO AVAILABLE TO THE PUBLIC THROUGH THE SECRETARY OF STATE OF NEW YORK. ASCO'S CONFLICT OF INTEREST POLICY IS POSTED ON ASCO'S WEBSITE AND IS AVAILABLE TO THE PUBLIC FROM ASCO UPON REQUEST. |
| FORM 990, PART IX, LINE 11G | OTHER PROFESSIONAL SERVICES: PROGRAM SERVICE EXPENSES 7,314,021. MANAGEMENT AND GENERAL EXPENSES 1,886,264. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 9,200,285. DATA CURATION: PROGRAM SERVICE EXPENSES 7,743,865. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 7,743,865. PUBLIC RELATIONS: PROGRAM SERVICE EXPENSES 750,795. MANAGEMENT AND GENERAL EXPENSES 228,122. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 978,917. TEMPORARY STAFF: PROGRAM SERVICE EXPENSES 601,862. MANAGEMENT AND GENERAL EXPENSES 124,702. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 726,564. |
| FORM 990, PART XI, LINE 9: | PRIOR PERIOD ADJUSTMENT 1,326,214. |
Schedule R IRS990ScheduleR
Id Disregarded Entities IdDisregardedEntitiesGrp (2 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | EINEIN | Primary ActivitiesPrimaryActivitiesTxt | Legal Domicile StateLegalDomicileStateCd | Total IncomeTotalIncomeAmt | End Of Year AssetsEndOfYearAssetsAmt | Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt |
|---|---|---|---|---|---|---|---|---|---|
| ASCO LEASING LLC | |||||||||
| 2318 MILL RD SUITE 800 | ALEXANDRIA | VA | 22314 | 273378225 | RENTAL | VA | $0 | $0 | ASCO |
| CANCERLINQ LLC | |||||||||
| 2318 MILL RD SUITE 800 | ALEXANDRIA | VA | 22314 | 472315885 | QUALITY IMPV | VA | $27,768,483 | $13,122,422 | ASCO |
Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp (3 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | EINEIN | Primary ActivitiesPrimaryActivitiesTxt | Legal Domicile StateLegalDomicileStateCd | Exempt Code SectionExemptCodeSectionTxt | Public Charity StatusPublicCharityStatusTxt | Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt | Controlled OrganizationControlledOrganizationInd |
|---|---|---|---|---|---|---|---|---|---|---|
| CONQUER CANCER FOUNDATION OF ASCO | ||||||||||
| 2318 MILL RD SUITE 800 | ALEXANDRIA | VA | 22314 | 311667995 | GRANTMAKING | VA | 501(C)(3) | LINE 7 | ASCO | Yes (1) |
| ASCO ASSOCIATION | ||||||||||
| 2318 MILL RD SUITE 800 | ALEXANDRIA | VA | 22314 | 833561693 | MEMBER SERVS | VA | 501(C)(6) | ASCO | Yes (1) | |
| ASCO ASSOCIATION POLITICAL ACTION COMM | ||||||||||
| 2318 MILL RD SUITE 800 | ALEXANDRIA | VA | 22314 | 844213157 | ADVOCACY | VA | 527 | ASCO ASSOC | 0 | |
Id Related Org Txbl Corp Tr IdRelatedOrgTxblCorpTrGrp
Related Organization Name RelatedOrganizationName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | CANCERLINQ LABS LLC | BusinessNameLine1Txt |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 2318 MILL ROAD SUITE 800 | AddressLine1Txt |
| City | ALEXANDRIA | CityNm |
| State Abbreviation | VA | StateAbbreviationCd |
| ZIP | 22314 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 881804716 | EIN |
| Primary Activities | DATABASE TECHNOLOGY | PrimaryActivitiesTxt |
| Legal Domicile State | VA | LegalDomicileStateCd |
| Direct Controlling NA | N/A | DirectControllingNACd |
| Entity Type | C | EntityTypeTxt |
| Controlled Organization | 0 | ControlledOrganizationInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Receipt Of Int Annts Rnts Rylts | Yes (1) | ReceiptOfIntAnntsRntsRyltsInd |
| Gift Grnt Or Cap Contri To Oth Org | Yes (1) | GiftGrntOrCapContriToOthOrgInd |
| Gift Grnt Cap Contri From Oth Org | Yes (1) | GiftGrntCapContriFromOthOrgInd |
| Loans Or Guarantees To Other Org | Yes (1) | LoansOrGuaranteesToOtherOrgInd |
| Loans Or Guarantees From Oth Org | 0 | LoansOrGuaranteesFromOthOrgInd |
| Div Related Organization | 0 | DivRelatedOrganizationInd |
| Asset Sale To Other Org | 0 | AssetSaleToOtherOrgInd |
| Asset Purchase From Other Org | 0 | AssetPurchaseFromOtherOrgInd |
| Asset Exchange | 0 | AssetExchangeInd |
| Rental Of Facilities To Oth Org | 0 | RentalOfFacilitiesToOthOrgInd |
| Rental Of Fclts From Oth Org | 0 | RentalOfFcltsFromOthOrgInd |
| Perform Of Services For Oth Org | Yes (1) | PerformOfServicesForOthOrgInd |
| Perform Of Services By Other Org | 0 | PerformOfServicesByOtherOrgInd |
| Sharing Of Facilities | 0 | SharingOfFacilitiesInd |
| Paid Employees Sharing | 0 | PaidEmployeesSharingInd |
| Reimbursement Paid To Other Org | Yes (1) | ReimbursementPaidToOtherOrgInd |
| Reimbursement Paid By Other Org | Yes (1) | ReimbursementPaidByOtherOrgInd |
| Transfer To Other Org | 0 | TransferToOtherOrgInd |
| Transfer From Other Org | 0 | TransferFromOtherOrgInd |
Transactions Related Org TransactionsRelatedOrgGrp (10 entries)
| Transaction TypeTransactionTypeTxt | InvolvedInvolvedAmt | Method Of Amount DeterminationMethodOfAmountDeterminationTxt |
|---|---|---|
| ASCO ASSOCIATION | ||
| A | $270,897 | FMV |
| CONQUER CANCER FOUNDATION OF ASCO | ||
| B | $3,566,050 | FMV |
| CONQUER CANCER FOUNDATION OF ASCO | ||
| C | $7,751,511 | FMV |
| ASCO ASSOCIATION | ||
| C | $75,000 | FMV |
| ASCO ASSOCIATION | ||
| D | $4,696,784 | FMV |
| ASCO ASSOCIATION | ||
| L | $1,318,578 | |
| CONQUER CANCER FOUNDATION OF ASCO | ||
| L | $98,104 | |
| CONQUER CANCER FOUNDATION OF ASCO | ||
| Q | $6,800,390 | |
| ASCO ASSOCIATION | ||
| Q | $2,895,608 | |
| ASCO ASSOCIATION | ||
| P | $306,785 | |